Single-center, Double-masked, Placebo-controlled Parallel-group Study of Pregnancy-related Hormones Estradiol and Medroxyprogesterone, in Conjunction With Hydrocortisone and Growth Hormone to Stimulate C-peptide Secretion in Women With T1DM.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Estradiol; Hydrocortisone; Medroxyprogesterone; Somatotropin receptor agonists
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 18 Apr 2018 Biomarkers information updated
- 25 Jul 2011 Planned initiation date changed from 1 Jul 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 25 Jul 2011 Planned end date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.